Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Odyssey Group Intl Inc (OP: ODYY ) 0.0185 UNCHANGED Streaming Delayed Price Updated: 2:08 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Odyssey Group Intl Inc < Previous 1 2 3 Next > Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. January 02, 2024 Via ACCESSWIRE Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. December 12, 2023 Via ACCESSWIRE Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion November 16, 2023 Via ACCESSWIRE Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders November 15, 2023 Via ACCESSWIRE Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. October 18, 2023 Via ACCESSWIRE Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate October 05, 2023 From Oragenics, Inc. Via Business Wire Odyssey Health Inc. Begins Trading on the OTCQB October 04, 2023 Via ACCESSWIRE Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS August 23, 2023 Via ACCESSWIRE Odyssey Health, Inc. Presents Data at the Special Operations Medical Association - Scientific Assembly June 08, 2023 Via ACCESSWIRE Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment March 30, 2023 McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on creating unique, life-enhancing medical products, is developing a novel... Via TheNewswire.com Odyssey Health, Inc. (ODYY) To Give Corporate Update at Scheduled Annual Meeting of Stockholders in January 2023 December 01, 2022 Via Investor Brand Network Topics Animal Testing Exposures Animal Testing BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Reports on Concussion Drug Progress, Provides Corporate Update November 23, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property World Cup 2022 to Feature New Protocol to Respond to Suspected Concussions November 22, 2022 Via Investor Brand Network Odyssey Health, Inc. (ODYY) Expands Executive Team of New Subsidiary in Strategic Move to Strengthen Marketing of Concussion, Neurological Therapies November 21, 2022 Via Investor Brand Network Surgical Team in Spain Completes First-Ever Intestinal Transplant November 17, 2022 Via Investor Brand Network BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Upcoming Annual Meeting of Stockholders November 15, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device November 14, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Study Finds Iron Causes Chronic Heart Failure in Heart Attack Survivors November 09, 2022 Via Investor Brand Network New Pharmaceutical Subsidiary Geared to Aid Odyssey Health, Inc. (ODYY) Development of Novel Solutions for Brain Related Medical Treatments November 07, 2022 Via Investor Brand Network Experts Concerned That Concussion Protocols Don’t Factor in Women November 04, 2022 Via Investor Brand Network BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Announces Expansion of Executive Team November 03, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device November 01, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Pleased with Safety Profile of Its PRV-002 Concussion Treatment October 31, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property New Research Uncovers Racial Disparities in Treatment of Heart Failure October 31, 2022 Via Investor Brand Network BioMedNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Designed to Expedite Return to Work, Play Following Concussive Episode October 26, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property New Experimental Drug May Reverse Brain Damage Caused by Concussions October 24, 2022 Via Investor Brand Network Odyssey Health, Inc. (ODYY) Updates Progress of its Concussion Drug Development Program; Communicating with the FDA for permission to start phase II clinical trial of its PRV-002 Drug Candidate October 18, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety BioMedNewsBreaks – Odyssey Health Inc.’s (ODYY) PRV-002 Designed to Mitigate Short- and Long-Term Effects of mTBI October 17, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Researchers Develop AI Tool That Scans Retina, Detects Heart Disease in One Minute October 17, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Odyssey Health, Inc. (ODYY) Seeking to Provide Solution to Concussion-Prone Military and NFL with Development of PRV-002 Drug Candidate October 14, 2022 Via Investor Brand Network < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
